Efzofitimod 3 mg/kg clinical trials

Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

This study is testing a new drug, efzofitimod, for people with lung sarcoidosis. Researchers want to see if it's safe and helps improve symptoms compared to a dummy treatment over 48 weeks. It's for adults already taking steroids for their condition.